- Home
- AGFY vs ELEV Comparison
AGFY vs ELEV Comparison
Compare AGFY & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGFY
- ELEV
- Stock Information
- Founded
- AGFY 2016
- ELEV 2019
- Country
- AGFY United States
- ELEV United States
- Employees
- AGFY N/A
- ELEV N/A
- Industry
- AGFY Military/Government/Technical
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- AGFY Consumer Discretionary
- ELEV Health Care
- Exchange
- AGFY Nasdaq
- ELEV Nasdaq
- Market Cap
- AGFY 41.0M
- ELEV 37.6M
- IPO Year
- AGFY 2021
- ELEV 2021
- Fundamental
- Price
- AGFY $16.25
- ELEV $0.50
- Analyst Decision
- AGFY
- ELEV Buy
- Analyst Count
- AGFY 0
- ELEV 6
- Target Price
- AGFY N/A
- ELEV $7.20
- AVG Volume (30 Days)
- AGFY 21.6K
- ELEV 1.0M
- Earning Date
- AGFY 04-14-2025
- ELEV 03-06-2025
- Dividend Yield
- AGFY N/A
- ELEV N/A
- EPS Growth
- AGFY N/A
- ELEV N/A
- EPS
- AGFY N/A
- ELEV N/A
- Revenue
- AGFY $10,385,000.00
- ELEV N/A
- Revenue This Year
- AGFY $468.67
- ELEV N/A
- Revenue Next Year
- AGFY N/A
- ELEV N/A
- P/E Ratio
- AGFY N/A
- ELEV N/A
- Revenue Growth
- AGFY N/A
- ELEV N/A
- 52 Week Low
- AGFY $2.71
- ELEV $0.42
- 52 Week High
- AGFY $84.44
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- AGFY 39.53
- ELEV 39.41
- Support Level
- AGFY $14.42
- ELEV $0.46
- Resistance Level
- AGFY $19.21
- ELEV $0.53
- Average True Range (ATR)
- AGFY 2.05
- ELEV 0.05
- MACD
- AGFY -0.25
- ELEV -0.00
- Stochastic Oscillator
- AGFY 24.90
- ELEV 36.30
About AGFY Agrify Corporation
Agrify Corp is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Its proprietary micro-environment-controlled Agrify Vertical Farming Units (VFUs) enable cultivators to produce high-quality products The products offered by the company include Integrated Grow Racks, LED Grow Lights, Hydroponics, and Vertical Farming Units.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.